CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). II. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE

. 1946 Jul;25(4):467–473. doi: 10.1172/JCI101729

PMCID: PMC435585 PMID: 16695339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Luetscher J. A., Eagle H., Longcope W. T., Watson E. B. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION. J Clin Invest. 1946 Jul;25(4):534–540. doi: 10.1172/JCI101735. [DOI] [PMC free article] [PubMed] [Google Scholar]
Sulzberger M. B., Baer R. L., Kanof A. CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION. J Clin Invest. 1946 Jul;25(4):474–479. doi: 10.1172/JCI101730. [DOI] [PMC free article] [PubMed] [Google Scholar]
Waters L. L., Stock C. BAL (BRITISH ANTI-LEWISITE). Science. 1945 Dec 14;102(2659):601–606. doi: 10.1126/science.102.2659.601. [DOI] [PubMed] [Google Scholar]